Connect your AI

AptarGroup ATR Pharma — Selling, research & development and administrative

Other segment segments

Beauty

$52.63M—

Closures

$24.95M—

Similar metrics at other companies

BAXPharmaceuticals — Selling, general and administrative expenses

$102M-1.0%

PFEBiopharma — Selling, informational and administrative expenses

$2.13B-2.5%

BAXPharmaceuticals — Research and development expenses

$22M-15.4%

BDXBioPharma Systems — Selling and administrative expense

$32M+14.3%

BDXBioPharma Systems — Segment Selling and Administrative as a Percent of Revenues

5.4%+0.6pp

VRTXPharmaceuticals — Selling and other commercial expenses

$313.6M+30.1%

Other financials

Income statement

Revenue$982.9M+10.8%

Gross profit$351.9M+4.6%

Operating income$107.5M-5.2%

Net income$72.7M-7.8%

EPS (diluted)$1.12-4.3%

Balance sheet

Cash & equivalents$225.0M+78.8%

Total debt$1.4B+32.7%

Total equity$2.6B+3.6%

Total assets$5.1B+12.6%

Cash flow

Operating cash flow$118.7M+43.5%

CapEx$65.4M+15.0%

Free cash flow$53.3M+106%

Valuation

Market cap$7.68B-17.9%

Enterprise value$8.89B-13.9%

P/E19.9×-5.4×

P/S2×-0.6×

Profitability

Gross margin36.7%-1.6pp

Operating margin12.8%-1.2pp

Net margin10%-0.4pp

FCF margin8.4%-2.1pp

Returns & leverage

Return on equity15%-0.2pp

Debt / equity0.5×+0.1×

Current ratio1.7×+0.4×

Where this comes from

Reported directly by AptarGroup in its filing.

Tagged under the XBRL concept atr:SellingResearchAndDevelopmentAndAdministrativeExpenses.

The official record: AptarGroup’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about AptarGroup's pharma — selling, research & development and administrative.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is AptarGroup's pharma — selling, research & development and administrative?: AptarGroup (ATR) reported pharma — selling, research & development and administrative of $68.12M in Q1 2026.
How has AptarGroup's pharma — selling, research & development and administrative changed year-over-year?: AptarGroup's pharma — selling, research & development and administrative increased by 9.0% year-over-year, from $62.48M to $68.12M.
What does pharma — selling, research & development and administrative mean?: Represents the operating expenses incurred for sales, marketing, administrative support, and research and development activities within the pharma segment. This reflects the investment in innovation and the overhead required to maintain market presence.